retatrutide clinical trials phase 2 trial retatrutide Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized 2a retatrutide clinical phase – retatrutide obesity phase 2 trial
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11


























